US Stock MarketDetailed Quotes

Collegium Pharmaceutical (COLL)

Watchlist
  • 46.900
  • +0.330+0.71%
Close Jan 15 15:59 ET
  • 46.900
  • 0.0000.00%
Post 20:01 ET
1.48BMarket Cap28.77P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Collegium Pharmaceutical (COLL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
31.42%209.36M
29.41%188M
22.66%177.76M
11.41%631.45M
21.51%181.95M
16.53%159.3M
7.18%145.28M
0.11%144.92M
22.17%566.77M
15.53%149.75M
Operating revenue
31.42%209.36M
29.41%188M
22.66%177.76M
11.41%631.45M
21.51%181.95M
16.53%159.3M
7.18%145.28M
0.11%144.92M
22.17%566.77M
15.53%149.75M
Cost of revenue
28.29%80.19M
46.16%79.62M
50.43%80.43M
5.61%254.11M
51.79%83.66M
10.83%62.51M
-11.75%54.47M
-20.63%53.47M
-5.44%240.6M
-30.96%55.12M
Gross profit
33.45%129.17M
19.36%108.38M
6.42%97.32M
15.69%377.34M
3.87%98.29M
20.52%96.79M
23.00%90.81M
18.16%91.46M
55.70%326.17M
90.06%94.63M
Operating expense
8.31%67.1M
69.93%73.64M
82.04%76.42M
32.13%210.36M
91.52%63.09M
75.52%61.96M
13.46%43.34M
-20.45%41.98M
-9.63%159.21M
-13.38%32.94M
Selling and administrative expenses
8.31%67.1M
69.93%73.64M
82.04%76.42M
32.13%210.36M
91.52%63.09M
75.52%61.96M
13.46%43.34M
-20.45%41.98M
-7.54%159.21M
-13.38%32.94M
Research and development costs
----
----
----
--0
----
----
----
----
--0
----
Operating profit
78.16%62.07M
-26.80%34.75M
-57.75%20.9M
0.01%166.98M
-42.94%35.2M
-22.60%34.84M
33.22%47.47M
100.89%49.47M
401.10%166.96M
424.69%61.69M
Net non-operating interest income expense
-23.40%-18.65M
-61.57%-18.08M
-44.45%-18.57M
11.41%-60M
-39.15%-20.84M
6.88%-15.11M
37.26%-11.19M
31.20%-12.85M
-8.94%-67.72M
23.38%-14.98M
Non-operating interest income
-5.00%3.12M
-45.80%2.38M
-50.41%2.23M
-10.50%13.98M
-57.89%1.81M
-27.72%3.28M
9.19%4.4M
63.34%4.49M
1,391.40%15.62M
318.99%4.3M
Non-operating interest expense
18.34%21.77M
31.28%20.46M
19.90%20.79M
-11.24%73.97M
17.49%22.65M
-11.43%18.39M
-28.71%15.59M
-19.08%17.34M
31.84%83.34M
-6.29%19.28M
Other net income (expense)
100.46%19K
104.98%358K
786K
64.20%-8.42M
2.91M
-4.15M
-7.18M
-23.5M
0
Special income (charges)
100.46%19K
104.98%358K
--786K
64.20%-8.42M
--2.91M
---4.15M
---7.18M
--0
---23.5M
--0
-Less：Restructuring and merger&acquisition
---19K
---358K
---786K
---2.91M
---2.91M
--0
--0
--0
--0
----
-Less:Other special charges
----
----
----
-51.80%11.33M
--0
--4.15M
--7.18M
----
--23.5M
--0
Income before tax
178.79%43.44M
-41.49%17.03M
-91.48%3.12M
30.15%98.57M
-63.03%17.27M
-45.87%15.58M
63.49%29.1M
308.59%36.62M
362.53%75.73M
699.54%46.71M
Income tax
91.02%11.93M
-46.88%5.04M
-92.09%705K
6.53%29.38M
-67.96%4.73M
-23.36%6.25M
98.14%9.49M
6,900.76%8.91M
817.24%27.58M
2,594.93%14.77M
Net income
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
Net income continuous Operations
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
Minority interest income
Net income attributable to the parent company
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
Basic earnings per share
244.83%1
-36.67%0.38
-90.70%0.08
49.65%2.14
-59.38%0.39
-52.46%0.29
57.89%0.6
268.63%0.86
293.24%1.43
557.14%0.96
Diluted earnings per share
211.11%0.84
-34.62%0.34
-90.14%0.07
44.19%1.86
-56.63%0.36
-49.06%0.27
52.94%0.52
239.22%0.71
274.32%1.29
495.24%0.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 31.42%209.36M29.41%188M22.66%177.76M11.41%631.45M21.51%181.95M16.53%159.3M7.18%145.28M0.11%144.92M22.17%566.77M15.53%149.75M
Operating revenue 31.42%209.36M29.41%188M22.66%177.76M11.41%631.45M21.51%181.95M16.53%159.3M7.18%145.28M0.11%144.92M22.17%566.77M15.53%149.75M
Cost of revenue 28.29%80.19M46.16%79.62M50.43%80.43M5.61%254.11M51.79%83.66M10.83%62.51M-11.75%54.47M-20.63%53.47M-5.44%240.6M-30.96%55.12M
Gross profit 33.45%129.17M19.36%108.38M6.42%97.32M15.69%377.34M3.87%98.29M20.52%96.79M23.00%90.81M18.16%91.46M55.70%326.17M90.06%94.63M
Operating expense 8.31%67.1M69.93%73.64M82.04%76.42M32.13%210.36M91.52%63.09M75.52%61.96M13.46%43.34M-20.45%41.98M-9.63%159.21M-13.38%32.94M
Selling and administrative expenses 8.31%67.1M69.93%73.64M82.04%76.42M32.13%210.36M91.52%63.09M75.52%61.96M13.46%43.34M-20.45%41.98M-7.54%159.21M-13.38%32.94M
Research and development costs --------------0------------------0----
Operating profit 78.16%62.07M-26.80%34.75M-57.75%20.9M0.01%166.98M-42.94%35.2M-22.60%34.84M33.22%47.47M100.89%49.47M401.10%166.96M424.69%61.69M
Net non-operating interest income expense -23.40%-18.65M-61.57%-18.08M-44.45%-18.57M11.41%-60M-39.15%-20.84M6.88%-15.11M37.26%-11.19M31.20%-12.85M-8.94%-67.72M23.38%-14.98M
Non-operating interest income -5.00%3.12M-45.80%2.38M-50.41%2.23M-10.50%13.98M-57.89%1.81M-27.72%3.28M9.19%4.4M63.34%4.49M1,391.40%15.62M318.99%4.3M
Non-operating interest expense 18.34%21.77M31.28%20.46M19.90%20.79M-11.24%73.97M17.49%22.65M-11.43%18.39M-28.71%15.59M-19.08%17.34M31.84%83.34M-6.29%19.28M
Other net income (expense) 100.46%19K104.98%358K786K64.20%-8.42M2.91M-4.15M-7.18M-23.5M0
Special income (charges) 100.46%19K104.98%358K--786K64.20%-8.42M--2.91M---4.15M---7.18M--0---23.5M--0
-Less：Restructuring and merger&acquisition ---19K---358K---786K---2.91M---2.91M--0--0--0--0----
-Less:Other special charges -------------51.80%11.33M--0--4.15M--7.18M------23.5M--0
Income before tax 178.79%43.44M-41.49%17.03M-91.48%3.12M30.15%98.57M-63.03%17.27M-45.87%15.58M63.49%29.1M308.59%36.62M362.53%75.73M699.54%46.71M
Income tax 91.02%11.93M-46.88%5.04M-92.09%705K6.53%29.38M-67.96%4.73M-23.36%6.25M98.14%9.49M6,900.76%8.91M817.24%27.58M2,594.93%14.77M
Net income 237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M
Net income continuous Operations 237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M
Minority interest income
Net income attributable to the parent company 237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M
Basic earnings per share 244.83%1-36.67%0.38-90.70%0.0849.65%2.14-59.38%0.39-52.46%0.2957.89%0.6268.63%0.86293.24%1.43557.14%0.96
Diluted earnings per share 211.11%0.84-34.62%0.34-90.14%0.0744.19%1.86-56.63%0.36-49.06%0.2752.94%0.52239.22%0.71274.32%1.29495.24%0.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -